Vitamin D-binding protein
| GC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | GC, DBP, DBP/GRD3, HEL-S-51, VDBG, VDBP, Gc-MAF, GcMAF, vitamin D binding protein, DBP-maf, VDB, GC vitamin D binding protein | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | OMIM: 139200; MGI: 95669; GeneCards: GC | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
GC Vitamin D binding protein,[5] also referred to as Vitamin D binding protein (DBP), is a protein that is encoded by the GC gene in Homo sapiens (modern humans).[5][6][7] DBP is genetically the oldest member of the albuminoid family and appeared early in the evolution of vertebrates.[8]
Structure
[edit]Human GC is a glycosylated alpha-globulin, 52.92 kDa in size.[9][10] Its 474 amino acids are encoded by a sequence of 1685 nucleotides (including the nucleotides preceding the protein-coding section, composed of the 5' UTR and 3' UTR) located at 4q13.3.[5][11] The primary structure contains 28 cysteine residues forming multiple disulfide bonds. GC contains 3 domains. Domain 1 is composed of 10 alpha helices, domain 2 of 9, and domain 3 of 4.[12]
Function
[edit]Vitamin D-binding protein belongs to the albumin gene family, together with human serum albumin and alpha-fetoprotein. It is a multifunctional protein found in plasma, ascitic fluid, cerebrospinal fluid (CSF), and on the surface of many cell types.[5]
It binds to various forms of vitamin D, including ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3), the 25-hydroxylated forms (calcifediol), and the active hormonal product, 1,25-dihydroxyvitamin D (calcitriol).[5] The major proportion of vitamin D in blood is bound to this protein. Once bound, it transports vitamin D and its plasma metabolites between the skin, liver, and kidney, and then on to the various target tissues.[5][7][13] The expression of GC, and therefore the production of GC Vitamin D binding protein, is restricted towards the liver; in an RNA-sequence (RNA-seq) study of tissues samples from 95 human individuals across 27 tissue representations analysed on December 19, 2024, GC was expressed primarily in the tissue of the liver, at a mean RPKM (reads per kilobase million) value of 1258.79 ± 214.721 across 3 samples.[5][14] In comparison, the next highest RPKM means were in the anatomically nearby gallbladder, at a value of 235.12 ± 73.639 across 3 samples, followed by the stomach, at a value of 23.974 ± 19.053 across 3 samples, the duodenum, at a value of 22.508 ± 6.514 across 2 samples, and the kidney, at a value of 12.033 ± 12.168 across 4 samples.[5] Other tissue samples held a negligible value in comparison to the liver, gallbladder, stomach, duodenum, and kidney.[5]
Beyond acting as the carrier protein for vitamin D and its metabolites, DBP also transports free fatty acids,[15] binds to actin[16] and may help prevent actin polymerization during tissue injury.[17] It also might serve as a macrophage activator, contributing to the inflammatory response by modulating T-cell activity.[18]
As Gc protein-derived macrophage activating factor it is a Macrophage Activating Factor (MAF) that has been tested for use as a cancer treatment that would activate macrophages against cancer cells.[19]
Production
[edit]It is synthesized by hepatic parenchymal cells and secreted into the blood circulation.[13]
Regulation
[edit]The transcription factor HFN1α is a positive regulator while HFN1β is a dominant negative regulator of DBP expression.[20]
Evolution
[edit]Phylogenetic analyses suggest that DBP diverged from ancestral albumin through gene duplication events that occurred after the separation of jawless fish (cyclostomes) from jawed vertebrates approximately 450 million years ago.[21] This timeline is supported by the apparent absence of DBP-like proteins in lampreys and hagfish, though these organisms retain vitamin D transport capability through alternative lipoprotein-mediated mechanisms.[22] DBP is found throughout jawed vertebrates, from bony fish to mammals, suggesting its evolution coincided with the development of calcified skeletons and more sophisticated calcium homeostasis requirements.[23]
Variation
[edit]Many genetic variants of the GC gene are known. They produce 6 main haplotypes and 3 main protein variants (Gc1S, Gc1F and Gc2).[24] The genetic variations are associated with differences in circulating 25-hydroxyvitamin D levels.[25] They have been proposed to account for some of the differences in vitamin D status in different ethnic groups,[26] and have been found to correlate with the response to vitamin D supplementation.[24]
References
[edit]
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000145321 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000035540 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- 1 2 3 4 5 6 7 8 9 "GC vitamin D binding protein". NCBI. Retrieved 2026-06-14.
- ↑ Mikkelsen M, Jacobsen P, Henningsen K (Jul 1977). "Possible localization of Gc-System on chromosome 4. Loss of long arm 4 material associated with father-child incompatibility within the Gc-System". Human Heredity. 27 (2): 105–107. doi:10.1159/000152857. PMID 558959.
- 1 2 "Entrez Gene: GC group-specific component (vitamin D binding protein)".
- ↑ Bouillon R, Schuit F, Antonio L, Rastinejad F (2020). "Vitamin D Binding Protein: A Historic Overview". Frontiers in Endocrinology. 10 910. doi:10.3389/fendo.2019.00910. PMC 6965021. PMID 31998239.
- ↑ "Protein Molecular Weight Calculator". www.sciencegateway.org. Retrieved 2026-06-14.
- ↑ "RecName: Full=Vitamin D-binding protein; Short=DBP; Short=VDB; AltName - Protein - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2026-06-14.
- ↑ "Homo sapiens GC vitamin D binding protein (GC), transcript variant 1, mRNA". National Center for Biotechnology Information. April 28, 2025.
- ↑ Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C (February 2002). "A structural basis for the unique binding features of the human vitamin D-binding protein". Nature Structural Biology. 9 (2): 131–136. doi:10.1038/nsb754. PMID 11799400. S2CID 38990672.
- 1 2 Norman AW (August 2008). "From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health". The American Journal of Clinical Nutrition. 88 (2): 491S–499S. doi:10.1093/ajcn/88.2.491S. PMID 18689389.
- ↑ "BTEP: What is the difference between RPKM, FPKM and TPM". 2020-04-02. Retrieved 2026-06-14.
- ↑ Williams MH, Van Alstyne EL, Galbraith RM (June 1988). "Evidence of a novel association of unsaturated fatty acids with Gc (vitamin D-binding protein)". Biochemical and Biophysical Research Communications. 153 (3): 1019–1024. doi:10.1016/S0006-291X(88)81330-5. PMID 3134016.
- ↑ Van Baelen H, Bouillon R, De Moor P (1980). "Vitamin D-binding protein (Gc-globulin) binds actin". Journal of Biological Chemistry. 255 (6): 2270–2272. doi:10.1016/S0021-9258(19)85885-4. PMID 6892638.
- ↑ Meier U, Gressner O, Lammert F, Gressner AM (July 2006). "Gc-globulin: roles in response to injury". Clinical Chemistry. 52 (7): 1247–1253. doi:10.1373/clinchem.2005.065680. PMID 16709624.
- ↑ Delanghe JR, Speeckaert R, Speeckaert MM (October 2015). "Behind the scenes of vitamin D binding protein: more than vitamin D binding". Best Practice & Research. Clinical Endocrinology & Metabolism. 29 (5): 773–786. doi:10.1016/j.beem.2015.06.006. PMID 26522461.
- ↑ Yamamoto N, Suyama H, Yamamoto N (July 2008). "Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF" ([PDF]). Translational Oncology. 1 (2): 65–72. doi:10.1593/tlo.08106. PMC 2510818. PMID 18633461.
- ↑ Bouillon R, Schuit F, Antonio L, Rastinejad F (2019). "Vitamin D Binding Protein: A Historic Overview". Frontiers in Endocrinology. 10 910. doi:10.3389/fendo.2019.00910. PMC 6965021. PMID 31998239.
- ↑ Gray JE, Doolittle RF (February 1992). "Characterization, primary structure, and evolution of lamprey plasma albumin". Protein Science. 1 (2): 289–302. doi:10.1002/pro.5560010211. PMC 2142188. PMID 1304910.
- ↑ Hay AW, Watson G (1976). "The plasma transport proteins of 25-hydroxycholecalciferol in fish, amphibians, reptiles and birds". Comparative Biochemistry and Physiology. B, Comparative Biochemistry. 53 (2): 167–172. doi:10.1016/0305-0491(76)90029-8. PMID 1253553.
- ↑ Andreeva AM (2022). "Evolutionary Transformations of Albumin Using the Example of Model Species of Jawless Agnatha and Bony Jawed Fish (Review)". Inland Water Biology. 15 (5): 641–658. doi:10.1134/S1995082922050029. ISSN 1995-0829.
- 1 2 Malik S, Fu L, Juras DJ, Karmali M, Wong BY, Gozdzik A, et al. (January–February 2013). "Common variants of the vitamin D binding protein gene and adverse health outcomes". Critical Reviews in Clinical Laboratory Sciences. 50 (1): 1–22. doi:10.3109/10408363.2012.750262. PMC 3613945. PMID 23427793.
- ↑ McGrath JJ, Saha S, Burne TH, Eyles DW (July 2010). "A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations". The Journal of Steroid Biochemistry and Molecular Biology. 121 (1–2): 471–477. doi:10.1016/j.jsbmb.2010.03.073. PMID 20363324. S2CID 20057294.
- ↑ Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al. (November 2013). "Vitamin D-binding protein and vitamin D status of black Americans and white Americans". The New England Journal of Medicine. 369 (21): 1991–2000. doi:10.1056/NEJMoa1306357. PMC 4030388. PMID 24256378.
- ↑ "Home | WikiPathways". www.wikipathways.org. Retrieved 2026-06-14.
Further reading
[edit]- Svasti J, Kurosky A, Bennett A, Bowman BH (April 1979). "Molecular basis for the three major forms of human serum vitamin D binding protein (group-specific component)". Biochemistry. 18 (8): 1611–1617. doi:10.1021/bi00575a036. PMID 218624.
- Braun A, Bichlmaier R, Cleve H (June 1992). "Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types". Human Genetics. 89 (4): 401–406. doi:10.1007/BF00194311. PMID 1352271. S2CID 1913655.
- Esteban C, Geuskens M, Ena JM, Mishal Z, Macho A, Torres JM, et al. (May 1992). "Receptor-mediated uptake and processing of vitamin D-binding protein in human B-lymphoid cells". The Journal of Biological Chemistry. 267 (14): 10177–10183. doi:10.1016/S0021-9258(19)50216-2. PMID 1374401.
- Szpirer C, Riviere M, Cortese R, Nakamura T, Islam MQ, Levan G, et al. (June 1992). "Chromosomal localization in man and rat of the genes encoding the liver-enriched transcription factors C/EBP, DBP, and HNF1/LFB-1 (CEBP, DBP, and transcription factor 1, TCF1, respectively) and of the hepatocyte growth factor/scatter factor gene (HGF)". Genomics. 13 (2): 293–300. doi:10.1016/0888-7543(92)90245-N. PMID 1535333.
- Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of Infection. 24 (3): 317–320. doi:10.1016/S0163-4453(05)80037-4. PMID 1602151.
- Yang F, Bergeron JM, Linehan LA, Lalley PA, Sakaguchi AY, Bowman BH (August 1990). "Mapping and conservation of the group-specific component gene in mouse". Genomics. 7 (4): 509–516. doi:10.1016/0888-7543(90)90193-X. PMID 1696927.
- Yang F, Luna VJ, McAnelly RD, Naberhaus KH, Cupples RL, Bowman BH (November 1985). "Evolutionary and structural relationships among the group-specific component, albumin and alpha-fetoprotein". Nucleic Acids Research. 13 (22): 8007–8017. doi:10.1093/nar/13.22.8007. PMC 322106. PMID 2415926.
- Yang F, Brune JL, Naylor SL, Cupples RL, Naberhaus KH, Bowman BH (December 1985). "Human group-specific component (Gc) is a member of the albumin family". Proceedings of the National Academy of Sciences of the United States of America. 82 (23): 7994–7998. Bibcode:1985PNAS...82.7994Y. doi:10.1073/pnas.82.23.7994. PMC 391428. PMID 2415977.
- Cooke NE, David EV (December 1985). "Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family". The Journal of Clinical Investigation. 76 (6): 2420–2424. doi:10.1172/JCI112256. PMC 424397. PMID 2416779.
- Schoentgen F, Metz-Boutigue MH, Jollès J, Constans J, Jollès P (June 1986). "Complete amino acid sequence of human vitamin D-binding protein (group-specific component): evidence of a three-fold internal homology as in serum albumin and alpha-fetoprotein". Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 871 (2): 189–198. doi:10.1016/0167-4838(86)90173-1. PMID 2423133.
- McNearney TA, Odell C, Holers VM, Spear PG, Atkinson JP (November 1987). "Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity". The Journal of Experimental Medicine. 166 (5): 1525–1535. doi:10.1084/jem.166.5.1525. PMC 2189652. PMID 2824652.
- Yang F, Naberhaus KH, Adrian GS, Gardella JM, Brissenden JE, Bowman BH (1987). "The vitamin D-binding protein gene contains conserved nucleotide sequences that respond to heavy metal, adipocyte and mitotic signals". Gene. 54 (2–3): 285–290. doi:10.1016/0378-1119(87)90499-9. PMID 2958390.
- Cooke NE, Willard HF, David EV, George DL (July 1986). "Direct regional assignment of the gene for vitamin D binding protein (Gc-globulin) to human chromosome 4q11-q13 and identification of an associated DNA polymorphism". Human Genetics. 73 (3): 225–229. doi:10.1007/BF00401232. PMID 3015768. S2CID 38816588.
- Nestler JE, McLeod JF, Kowalski MA, Strauss JF, Haddad JG (May 1987). "Detection of vitamin D binding protein on the surface of cytotrophoblasts isolated from human placentae". Endocrinology. 120 (5): 1996–2002. doi:10.1210/endo-120-5-1996. PMID 3552627.
- Pierce EA, Dame MC, Bouillon R, Van Baelen H, DeLuca HF (December 1985). "Monoclonal antibodies to human vitamin D-binding protein". Proceedings of the National Academy of Sciences of the United States of America. 82 (24): 8429–8433. Bibcode:1985PNAS...82.8429P. doi:10.1073/pnas.82.24.8429. PMC 390929. PMID 3936035.
- Wooten MW, Nel AE, Goldschmidt-Clermont PJ, Galbraith RM, Wrenn RW (October 1985). "Identification of a major endogenous substrate for phospholipid/Ca2+-dependent kinase in pancreatic acini as Gc (vitamin D-binding protein)". FEBS Letters. 191 (1): 97–101. doi:10.1016/0014-5793(85)81001-2. PMID 4054306. S2CID 29613843.
- Constans J, Oksman F, Viau M (August 1981). "Binding of the apo and holo forms of the serum vitamin D-binding protein to human lymphocyte cytoplasm and membrane by indirect immunofluorescence". Immunology Letters. 3 (3): 159–162. doi:10.1016/0165-2478(81)90120-6. PMID 7026425.
- Braun A, Kofler A, Morawietz S, Cleve H (December 1993). "Sequence and organization of the human vitamin D-binding protein gene". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1216 (3): 385–394. doi:10.1016/0167-4781(93)90005-x. PMID 7505619.
- Swamy N, Roy A, Chang R, Brisson M, Ray R (April 1995). "Affinity purification of human plasma vitamin D-binding protein". Protein Expression and Purification. 6 (2): 185–188. doi:10.1006/prep.1995.1023. PMID 7606167.